Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D

IMPORTANCE: Before 2009, only 4 self-administered disease-modifying therapies (DMTs) were approved for the treatment of multiple sclerosis (MS). Since then, 7 new agents have entered the market. OBJECTIVE: To assess trends in prices, market share, and spending on self-administered DMTs for MS in Med...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Neurol
Autori principali: San-Juan-Rodriguez, Alvaro, Good, Chester B., Heyman, Rock A., Parekh, Natasha, Shrank, William H., Hernandez, Inmaculada
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2019
Soggetti:
Brief Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714023/
https://ncbi.nlm.nih.gov/pubmed/31449293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.2711
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi